Connection

Adviye Ergul to Diabetes Mellitus, Experimental

Back to Details
This is a "connection" page, showing publications Adviye Ergul has written about Diabetes Mellitus, Experimental.
Adviye Ergul
Connection Strength
11.090
Diabetes Mellitus, Experimental
  1. Acute Ischemic Stroke by Middle Cerebral Artery Occlusion in Rat Models of Diabetes: Importance of Pre-op and Post-op Care, Severity of Hyperglycemia, and Sex. Methods Mol Biol. 2023; 2616:467-479.
    View in: PubMed
    Score: 0.696
  2. Deferoxamine prevents poststroke memory impairment in female diabetic rats: potential links to hemorrhagic transformation and ferroptosis. Am J Physiol Heart Circ Physiol. 2023 02 01; 324(2):H212-H225.
    View in: PubMed
    Score: 0.694
  3. Cerebral microvascular matrix metalloproteinase-3 (MMP3) contributes to vascular injury after stroke in female diabetic rats. Neurochem Int. 2023 01; 162:105462.
    View in: PubMed
    Score: 0.693
  4. Impact of diabetes and ischemic stroke on the cerebrovasculature: A female perspective. Neurobiol Dis. 2022 06 01; 167:105667.
    View in: PubMed
    Score: 0.656
  5. Delayed Administration of Angiotensin Receptor (AT2R) Agonist C21 Improves Survival and Preserves Sensorimotor Outcomes in Female Diabetic Rats Post-Stroke through Modulation of Microglial Activation. Int J Mol Sci. 2021 Jan 29; 22(3).
    View in: PubMed
    Score: 0.609
  6. Deferoxamine Treatment Prevents Post-Stroke Vasoregression and Neurovascular Unit Remodeling Leading to Improved Functional Outcomes in Type 2 Male Diabetic Rats: Role of Endothelial Ferroptosis. Transl Stroke Res. 2021 08; 12(4):615-630.
    View in: PubMed
    Score: 0.592
  7. Diabetes-related sex differences in the brain endothelin system following ischemia in vivo and in human brain endothelial cells in vitro. Can J Physiol Pharmacol. 2020 Sep; 98(9):587-595.
    View in: PubMed
    Score: 0.590
  8. Delayed Administration of Angiotensin II Type 2 Receptor (AT2R) Agonist Compound 21 Prevents the Development of Post-stroke Cognitive Impairment in Diabetes Through the Modulation of Microglia Polarization. Transl Stroke Res. 2020 08; 11(4):762-775.
    View in: PubMed
    Score: 0.562
  9. Diabetic Stroke Promotes a Sexually Dimorphic Expansion of T Cells. Neuromolecular Med. 2019 12; 21(4):445-453.
    View in: PubMed
    Score: 0.544
  10. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Pharmacol Res. 2019 04; 142:237-250.
    View in: PubMed
    Score: 0.533
  11. Poststroke cognitive impairment and hippocampal neurovascular remodeling: the impact of diabetes and sex. Am J Physiol Heart Circ Physiol. 2018 11 01; 315(5):H1402-H1413.
    View in: PubMed
    Score: 0.514
  12. Inhibition of Toll-Like Receptor-4 (TLR-4) Improves Neurobehavioral Outcomes After Acute Ischemic Stroke in Diabetic Rats: Possible Role of Vascular Endothelial TLR-4. Mol Neurobiol. 2019 Mar; 56(3):1607-1617.
    View in: PubMed
    Score: 0.508
  13. TLR2 knockout protects against diabetes-mediated changes in cerebral perfusion and cognitive deficits. Am J Physiol Regul Integr Comp Physiol. 2017 06 01; 312(6):R927-R937.
    View in: PubMed
    Score: 0.464
  14. Diabetes-mediated middle cerebral artery remodeling is restored by linagliptin: Interaction with the vascular smooth muscle cell endothelin system. Life Sci. 2016 Aug 15; 159:76-82.
    View in: PubMed
    Score: 0.433
  15. Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes. Life Sci. 2016 Aug 15; 159:90-96.
    View in: PubMed
    Score: 0.432
  16. Relationship of endothelin-1 and NLRP3 inflammasome activation in HT22 hippocampal cells in diabetes. Life Sci. 2016 Aug 15; 159:97-103.
    View in: PubMed
    Score: 0.432
  17. Linagliptin attenuates diabetes-induced cerebral pathological neovascularization in a blood glucose-independent manner: Potential role of ET-1. Life Sci. 2016 Aug 15; 159:83-89.
    View in: PubMed
    Score: 0.425
  18. Dual endothelin receptor antagonism with bosentan reverses established vascular remodeling and dysfunctional angiogenesis in diabetic rats: relevance to glycemic control. Life Sci. 2014 Nov 24; 118(2):268-73.
    View in: PubMed
    Score: 0.374
  19. Late dual endothelin receptor blockade with bosentan restores impaired cerebrovascular function in diabetes. Life Sci. 2014 Nov 24; 118(2):263-7.
    View in: PubMed
    Score: 0.374
  20. Vascularization pattern after ischemic stroke is different in control versus diabetic rats: relevance to stroke recovery. Stroke. 2013 Oct; 44(10):2875-82.
    View in: PubMed
    Score: 0.362
  21. Magnetic resonance imaging reveals microemboli-mediated pathological changes in brain microstructure in diabetic rats: relevance to vascular cognitive impairment/dementia. Clin Sci (Lond). 2022 11 11; 136(21):1555-1570.
    View in: PubMed
    Score: 0.172
  22. Diabetic rats are more susceptible to cognitive decline in a model of microemboli-mediated vascular contributions to cognitive impairment and dementia. Brain Res. 2020 12 15; 1749:147132.
    View in: PubMed
    Score: 0.149
  23. Inhibition of Ephrin-B2 in brain pericytes decreases cerebral pathological neovascularization in diabetic rats. PLoS One. 2019; 14(1):e0210523.
    View in: PubMed
    Score: 0.132
  24. Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes. Vascul Pharmacol. 2007 Aug-Sep; 47(2-3):125-30.
    View in: PubMed
    Score: 0.059
  25. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol. 2005 Apr 29; 4:5.
    View in: PubMed
    Score: 0.051
  26. Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke. Neurochem Int. 2022 09; 158:105375.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.